Skip to main content

Find Clinical Trials

Home
Conditions
Philadelphia Chromosome Negative Chronic Myelogenous Leukemia

Clinical trial condition

Philadelphia Chromosome Negative Chronic Myelogenous Leukemia

Explore clinical trials studying Philadelphia Chromosome Negative Chronic Myelogenous Leukemia. Study availability and eligibility vary by location and protocol.

4 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Philadelphia Chromosome Negative Chronic Myelogenous Leukemia trial results

Not yet recruiting

Metabolic Syndrome and Risk of Chronic Philadelphia Negative Myeloproliferative Neoplasms

NCT07814560

Conditions: Philadelphia Chromosome Negative Chronic Myelogenous Leukemia
Locations: Not specified

View Trial Details

Completed

Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies

NCT01427881

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Megakaryoblastic Leukemia (M7), +138 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

3-AP and Fludarabine in Treating Patients With Myeloproliferative Disorders, Chronic Myelomonocytic Leukemia, or Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia

NCT00381550

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Blast Crisis, +37 more
Locations: Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States

View Trial Details

Completed

Vorinostat and Decitabine in Treating Patients With Relapsed, Refractory, or Poor-Prognosis Hematologic Cancer or Other Diseases

NCT00357708

Conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), +33 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details